Lannett grants the distribution rights for authorized generic version of Toprol-XL to Aralez Pharmaceuticals
30 November 2017 -

Pharmaceutical company Lannett Company Inc (NYSE:LCI) reported on Wednesday the launch of a US distribution agreement for its authorised generic Toprol-XL under its cardiovascular product offering with Aralez Pharmaceuticals Trading DAC.

Under the terms of the agreement, Aralez, an Irish company, is provided with the exclusive distributor rights to Lannett's Toprol-XL (Metoprolol Succinate) Extended Release Tablets in 25 mg, 50 mg, 100 mg and 200mg in the US.

According to the company, Metoprolol Succinate extended release is a beta-blocker used to treat chest pain (angina), heart failure and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.

For the 12 months ended September 2017, total US sales at Average Wholesale Price (AWP) of Metoprolol Succinate extended release tablets 25 mg, 50 mg, 100 mg and 200 mg were approximately USD690m, according to IMS.

Financial terms were not disclosed by the companies.